Oleic acid-induced metastasis of KRAS/p53-mutant colorectal cancer relies on concurrent KRAS activation and IL-8 expression bypassing EGFR activation
Theranostics · 2023
DOI: 10.7150/thno.85855 ↗Kurz gefasst
Fachartikel in der Zeitschrift Theranostics, 2023. Verfasst von Chih-Jie Shen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Institute of Medical Science, College of Medicine, Taipei Medical University, Taipei 110, Taiwan, ROC. Hauptthemen laut MEDLINE: Colonic Neoplasms, Hydroxymethylglutaryl-CoA Reductase Inhibitors. Die Arbeit wurde bisher 8-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Graduate Institute of Medical Science, College of Medicine, Taipei Medical University, Taipei 110, Taiwan, ROC.
- Division of Colorectal Surgery, Department of Surgery, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan 701, Taiwan, ROC.
- Department of Pharmacology, College of Medicine, National Cheng Kung University, Tainan 701, Taiwan, ROC.
Zitieren
APA
Shen, C. J., Chan, R. H., Lin, B. W., Li, N. C., Huang, Y. H., Chang, W. C., & Chen, B. K. (2023). Oleic acid-induced metastasis of KRAS/p53-mutant colorectal cancer relies on concurrent KRAS activation and IL-8 expression bypassing EGFR activation. Theranostics. https://doi.org/10.7150/thno.85855
Vancouver
Shen CJ, Chan RH, Lin BW, Li NC, Huang YH, Chang WC, et al. Oleic acid-induced metastasis of KRAS/p53-mutant colorectal cancer relies on concurrent KRAS activation and IL-8 expression bypassing EGFR activation. Theranostics. 2023. doi:10.7150/thno.85855
BibTeX
@article{Shen2023,
author = {Shen, Chih-Jie and Chan, Ren-Hao and Lin, Bo-Wen and Li, Nien-Chi and Huang, Ying-Hsuan and Chang, Wen-Chang and Chen, Ben-Kuen},
title = {Oleic acid-induced metastasis of KRAS/p53-mutant colorectal cancer relies on concurrent KRAS activation and IL-8 expression bypassing EGFR activation},
journal = {Theranostics},
year = {2023},
doi = {10.7150/thno.85855}
}
EUVIMED